Navigation Links
NLP Logix Announces Joint Product Development Agreement with Mayo Clinic using Deep Learning and Deployment onto Microsoft Azure
Date:7/26/2017

NLP Logix today announced a collaboration to develop deep learning algorithms targeted towards leveraging the years of diagnostic excellence by Mayo Clinic and the experience in developing and deploying artificial intelligence solutions by NLP Logix. The first product suite will be distributed through the Microsoft Azure platform and will focus on assisting physicians to more accurately and efficiently diagnose strokes in patients, one of the leading causes of death and debilitation in the world.

Artificial intelligence has most recently been associated with self-driving cars, facial recognition on FaceBook and Google, and Amazon’s home device offerings. This collaboration with Mayo Clinic is intended to bring this breakthrough technology to healthcare.

“This collaboration is bringing together the clinical expertise of Mayo Clinic, the extensive deep learning infrastructure and experience we have gained over the past six years here at NLP Logix, and the ability to quickly distribute these models via Azure,” said Matt Berseth, Lead Scientist, NLP Logix. “Artificial intelligence takes massive amounts of data to achieve results that are on par with humans and accurate data is essential to success. We're excited to collaborate with the world-renowned Mayo Clinic to develop products for the healthcare industry and we know we are working with the best to be able to deliver significant clinical value.”

“We are excited to be on the forefront of delivering the promise of artificial intelligence to improve patient care,” said W. David Freeman, M.D., neurologist at the Mayo Clinic campus in Florida. “To begin, we are focusing on developing a suite of stroke detection algorithms, which will be trained using the vast amount of de-identified clinical data Mayo Clinic has collected over the years.

The growing number of data science competitions sponsored by industry leading technology companies in collaboration with clinical research organizations across the world, highlight the significance of research in the area of deep learning in healthcare. This collaboration between NLP Logix, Mayo Clinic and Microsoft, will accelerate bringing deep learning theory from the lab to deliver real world value to the patient.

“Deep learning has shown early promise to be able to make significant contributions to the science of medicine and improve patient care,” said Charles Bruce, M.D., cardiologist at the Mayo Clinic campus in Florida. “We are excited to accelerate the potentials of artificial intelligence into true clinical value to our patients across the world.”

Mayo Clinic, Dr. W. David Freeman and Dr. Charles Bruce have a financial interest in the technology referenced in this news release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.

About NLP Logix
NLP Logix is an advanced analytics and machine learning data product and services company, which has grown from a vision in 2011 to one of the fastest growing teams of deep learning practitioners. NLP Logix delivers its solutions through LogixStudio, the company’s proprietary platform that gives a customer the ability to quickly leverage the growing library of algorithms and deploy them into their workflow. NLP Logix is delivering predictive modeling and machine learning solutions to customers across a wide swath of industries, including financial services, energy, healthcare, government, human resources and others. NLP Logix was recently recognized as one of the top 50 Fastest Growing Companies in Northeast Florida by the Jacksonville Business Journal for the second year in a row. For more information, please visit http://www.nlplogix.com.

Read the full story at http://www.prweb.com/releases/2017/07/prweb14542277.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Resverlogix desincorpora RVX Therapeutics Inc. para sus accionistas
2. Resverlogix Announces Annual General Meeting Voting Results
3. Resverlogix Names Michael Sweeney, M.D., as Senior Vice President of Clinical Development
4. Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program
5. Resverlogix Presents at the Prestigious American College of Cardiology 64th Annual Scientific Session & Expo (ACC.15)
6. Resverlogix Receives Two Patents for RVX-208 in China
7. Resverlogix Presents New Data at 52nd Annual European Renal Association - European Dialysis & Transplant Association Congress (ERA-EDTA)
8. Resverlogix Reports on the Beneficial Effects of RVX-208 on Glucose Metabolism in Prediabetes Mellitus at the American Diabetes Associations (ADA) Scientific Sessions in Boston, MA
9. Resverlogix to Present at the 2015 Bio International Convention
10. Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority
11. Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... A ... pregnancy rates in frozen and fresh in vitro fertilization (IVF) transfer ... age to IVF success. , After comparing the results from the fresh and ...
(Date:10/10/2017)... Poway, California (PRWEB) , ... October 10, 2017 , ... ... afternoon speaking at his local San Diego Rotary Club. The event ... San Diego, CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined ...
(Date:10/9/2017)... Oct. 9, 2017  BioTech Holdings announced today ... which its ProCell stem cell therapy prevents limb ... The Company, demonstrated that treatment with ProCell resulted ... saved as compared to standard bone marrow stem ... resulted in reduction of therapeutic effect.  ...
(Date:10/7/2017)... Phoenix, Arizona (PRWEB) , ... ... ... than 15 years’ experience providing advanced instruments and applications consulting for microscopy ... the in-house expertise in application consulting, Nanoscience Analytical offers a broad range ...
Breaking Biology Technology:
(Date:5/6/2017)... RAM Group , Singaporean based ... in biometric authentication based on a novel  ... to perform biometric authentication. These new sensors are based on ... Ram Group and its partners. This sensor will have ... and security. Ram Group is a next generation ...
(Date:4/19/2017)... The global military biometrics market ... by the presence of several large global players. The ... major players - 3M Cogent, NEC Corporation, M2SYS Technology, ... 61% of the global military biometric market in 2016. ... military biometrics market boast global presence, which has catapulted ...
(Date:4/17/2017)... April 17, 2017 NXT-ID, Inc. (NASDAQ: ... the filing of its 2016 Annual Report on Form 10-K on ... ... is available in the Investor Relations section of the Company,s website ... SEC,s website at http://www.sec.gov . 2016 Year Highlights: ...
Breaking Biology News(10 mins):